BRISTOL MYERS SQUIBB CO Quarterly Depreciation in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Bristol Myers Squibb Co quarterly/annual Depreciation history and growth rate from Q1 2010 to Q3 2024.
  • Bristol Myers Squibb Co Depreciation for the quarter ending September 30, 2024 was $166M, a 9.93% increase year-over-year.
  • Bristol Myers Squibb Co Depreciation for the twelve months ending September 30, 2024 was $645M, a 7.32% increase year-over-year.
  • Bristol Myers Squibb Co annual Depreciation for 2023 was $611M, a 4.09% increase from 2022.
  • Bristol Myers Squibb Co annual Depreciation for 2022 was $587M, a 5.01% increase from 2021.
  • Bristol Myers Squibb Co annual Depreciation for 2021 was $559M, a 4.61% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $645M $166M +$15M +9.93% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $630M $161M +$10M +6.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $620M $155M +$9M +6.16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $611M $163M +$10M +6.54% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $601M $151M +$3M +2.03% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $598M $151M +$10M +7.09% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $588M $146M +$1M +0.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $587M $153M +$16M +11.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $571M $148M +$4M +2.78% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $567M $141M -$2M -1.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $569M $145M +$10M +7.41% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $559M $137M +$2M +1.48% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $557M $144M +$8M +5.88% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $549M $143M -$2M -1.38% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $551M $135M -$35M -20.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $586M $135M -$18M -11.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $604M $136M +$1M +0.74% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $603M $145M +$12M +9.02% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $591M $170M +$37M +27.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $554M $153M +$14M +10.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $540M $135M +$8M +6.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $532M $133M +$7M +5.56% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $525M $133M +$20M +17.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $505M $139M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-10
Q3 2018 $127M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $126M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $113M -$53M -31.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-25
Q1 2017 $166M +$63M +61.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q1 2016 $103M -$30M -22.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q1 2015 $133M -$5M -3.62% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q1 2014 $138M +$30M +27.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q1 2013 $108M +$23M +27.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q1 2012 $85M -$32M -27.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q1 2011 $117M -$5M -4.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q1 2010 $122M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.